First patient enrolled in REFREH study First patient enrolled in REFREH study Read the press realease Previous Post (p) August 28th: Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure Next Post (n) Testimony of Denis, shareholder since 2016 (in French)
